69 A common antimicrobial additive increases colonic inflammation and colitis-associated colon tumorigenesis in mice.

68 An ingestible bacterial-electronic system to monitor gastrointestinal health.

67 Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection.

66 C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions.

65 Integrated in vivo multiomics analysis identifies p21-activated kinase signaling as a driver of colitis.

64 Targeting of p53- and PUMA-dependent apoptosis protects intestinal stem cells, but not cancer cells, against chemotherapy.

63 Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism.

62 Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria.

61 Elevated d-2-hydroxyglutarate during colitis drives progression to colorectal cancer.

60 Precision editing of the gut microbiota ameliorates colitis.

Free Images for Presentation: sunipix SUNIPIX